Steve Jobs' medical leave: Will Apple suffer without him?

Apple's superstar CEO is taking an indefinite leave to combat unspecified health problems. Will his absence cost Apple its leading edge?

When Steve Jobs went on medical leave in 2009 he vowed to return in six months; the length of this absence, however, was unspecified.
(Image credit: Getty)

Apple announced Monday that its visionary chief executive and cofounder, Steve Jobs, is taking an indefinite leave of absence "to focus on [his] health." Neither Jobs nor the company elaborated on Jobs' condition, and despite Apple's red-hot product lineup, investors in Europe sent Apple's stock plummeting on the news (U.S. markets were closed Monday). Jobs says he will stay on as CEO, but handed "day-to-day operations" over to COO Tim Cook, who also ran the company when Jobs took medical leaves in 2004 and 2009 to battle pancreatic cancer and have a liver transplant. Apple thrived during those periods, but will it suffer now if Jobs is away for long — or even departs permanently? (Watch an AP report about Jobs' announcement)

This is going to hurt: Investors will punish Apple over this announcement, and rightly so, says Charles Arthur in The Guardian. Many of them "see Apple as Jobs' creation — and him as the engine of its progress," its DNA, and the final arbiter of all design decisions. Cook is a good manager, but he lacks Jobs' magic touch and "showman's ability that ignites the passions of Apple's many fans." In fact, it's not clear anybody "could possibly follow Jobs if the worst happens."

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up